A multidisciplinary approach has been shown to be of benefit in the prevention of lower limb ulceration and amputation in patients with diabetes, but there is less information on the role of such an approach in patients receiving dialysis treatment.
← Objective
The purpose of the present study was to determine whether the institution of a chiropody program would result in fewer amputations in diabetic patients on peritoneal dialysis (PD).
← Design
Retrospective chart review.
← Setting
The PD program at a tertiary-care hospital.
← Patients
Patients with diabetes that were enrolled in the PD program between January 1997 and December 1999, inclusive, that were offered the opportunity to see a chiropodist, and that agreed to be seen. A total of 132 patients were included.
← Intervention
Education about foot care, assessment, and, in some instances, treatment by a chiropodist.
← Results
Patients with an amputation were more likely to be male (p < 0.01) and have peripheral vascular disease (p < 0.001) compared to those without an amputation. They also had a lower average mean arterial pressure (p < 0.05), lower weekly creatinine clearance (p < 0.01), higher mean erythropoietin dose (p < 0.05), and longer duration of end-stage renal disease (p < 0.001). Factors that were predictive of shorter time to death or amputation were older age [hazard ratio (HR) = 1.03, p < 0.05], peripheral vascular disease (HR = 2.66, p < 0.01), and cerebrovascular disease (HR = 2.70, p < 0.01). Being seen by a chiropodist was protective (HR = 0.39, p < 0.01).
← Conclusion
The current study suggests that a chiropody program may help to prevent amputation in patients with diabetes on PD.
1999 Report, Volume 1: Dialysis and Renal Transplantation.Canadian Organ Replacement Register.Ottawa: Canadian Institute for Health Information; 1999 June.
2.
SchömigM., RitzE., StandiE., AllenbergJ.The diabetic foot in the dialyzed patient.J Am Soc Nephrol2000; 11: 1153–9.
3.
EggersP.W., GohdesD., PughJ.Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population.Kidney Int1999; 56: 1524–33.
4.
HillM.N., HiltonS.C., YlitaloM., FeldmanH.I., HolechekM.J., BenedictG.W.Risk of foot complications in long-term diabetic patients with and without ESRD: A preliminary study.ANNA J1996; 23: 381–6.
5.
KornP., HoenigS.J., SkillmanJ.J., KentK.C.Is lower extremity revascularization worthwhile in patients with end-stage renal disease?Surgery2000; 128: 472–9.
MasonJ., O'KeeffeC., McIntoshA., HutchinsonA., BoothA., YoungR.J.A systematic review of foot ulcer in patients with Type 2 diabetes mellitus: Prevention.Diabet Med1999; 16: 801–12.
8.
EdmondsM.E., BlundellM.P., MorrisM.E., ThomasE.M., CottonL.T., WatkinsP.J.Improved survival of the diabetic foot: The role of a specialized foot clinic.Q J Med1986; 60: 763–71.
9.
LarssonJ., ApelqvistJ., AgardhC.D., StenstromA.Decreasing incidence of major amputation in diabetic patients: A consequence of a multidisciplinary foot care team approach?Diabet Med1995; 12: 770–6.
10.
FosterA.V., SnowdenS., GrenfellA., WatkinsP.J., EdmondsM.E.Reduction of gangrene and amputations in diabetic renal transplant patients: The role of a special foot clinic.Diabet Med1995; 12: 632–5.
11.
RichbourgM.J.Preventing amputations in patients with end stage renal disease: Whatever happened to foot care?ANNA J1998; 25: 13–20.
12.
WakeenM., ZimmermanS.W.Association between human recombinant EPO and peripheral vascular disease in diabetic patients receiving peritoneal dialysis.Am J Kidney Dis1998; 32: 488–93.
